A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Verastem, Inc.
ALX Oncology Inc.
NiKang Therapeutics, Inc.
AstraZeneca
Eli Lilly and Company
Pliant Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Compass Therapeutics
Eli Lilly and Company
Kivu Bioscience Inc.
Achieve Life Sciences
BicycleTx Limited
Astellas Pharma Inc
Eli Lilly and Company
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Plexium, Inc.
Deciphera Pharmaceuticals, LLC
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
AstraZeneca
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
Alterome Therapeutics, Inc.
IDEAYA Biosciences
Pfizer
Incyte Corporation
Aulos Bioscience, Inc.
Mirati Therapeutics Inc.
Aptamer Sciences, Inc.
AstraZeneca
GlaxoSmithKline
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Orano Med LLC
Conjupro Biotherapeutics, Inc.
Regeneron Pharmaceuticals
Novartis
Frontier Medicines Corporation
Boehringer Ingelheim
PMV Pharmaceuticals, Inc
Ankyra Therapeutics, Inc
Daiichi Sankyo
N-Power Medicine
ViroMissile, Inc.
AstraZeneca
Novartis
Pfizer